Navigation Links
Nonin Medical Announces Mark VanderWerf, Vice President-eHealth, Elected to American Telemedicine Association College of Fellows
Date:5/2/2011

MINNEAPOLIS, May 2, 2011 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced that Mark VanderWerf, Nonin's Vice President of eHealth, has been elected to the American Telemedicine Association (ATA) College of Fellows. Election to the College is a high honor that recognizes significant achievements in telemedicine, in addition to service to the ATA and the general telemedicine community. Nonin Medical made the announcement at the ATA 16th Annual Meeting and Exposition in Tampa, Florida, where the company is demonstrating its eHealth solutions at Booth 306.

"I am honored to be elected to the ATA College of Fellows," VanderWerf said. "ATA is the leading international organization promoting the use of advanced remote medical technologies to improve healthcare quality, equity and affordability throughout the world," said VanderWerf. "I am excited to be in a position to help the association achieve these goals." The ATA annually elects less than one percent of its current membership as new Fellows. Fellows are appointed to a life-time term.

VanderWerf is a globally recognized speaker, author and thought leader in the telehealth space. A 19-year industry veteran, he is the founder of AMD Global Telemedicine, Inc., the world's leading supplier of medical devices for telemedicine. VanderWerf is a former board member of the ATA and a founding board member of the International Society for Telemedicine and eHealth. As Vice President of eHealth for Nonin Medical, VanderWerf is responsible for defining new product and market opportunities while educating customers about the benefits of pulse oximetry for chronic disease management and the advantages of using Nonin eHealth solutions, in particular.

New Nonin Medical Technologies Showcased at ATA booth #306

Nonin Medical will demonstrate its Bluetooth®-enabled and Continua™ and Microsoft® HealthVault™-certified remote monitoring products at ATA booth #306, Monday, May 2, and Tuesday, May 3, during exhibitor hours. Visitors can also see Nonin Medical's new low power Xpod®, Model 3012LP, external pulse oximeter for OEM customers and the new Wrist-Ox2™ Model 3150 wrist-worn pulse oximeter for ambulatory and sleep studies. In addition, Nonin Medical will demonstrate the world's first end-to-end health solution (enabled by Continua™-certified interoperability), where visitors can learn how data from consumer health devices can be securely transmitted to hospitals, medical offices, social media and patient information systems for a complete healthcare management tool.

About Nonin Medical, Inc.

Nonin Medical, Inc. invented finger pulse oximetry and specializes in the design and manufacturing of noninvasive physiological monitoring solutions. Headquartered in Minneapolis, Minn. with an additional distribution and service center in Hudiksvall, Sweden, Nonin distributes its pulse and cerebral oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries and has more than 100 OEM partners worldwide.

Nonin Medical's vision of remote monitoring focuses on how to provide cost-effective, accurate physiological data exchanges with no proprietary boundaries. As an ATA Sustaining President's Circle Member and founding member of the Continua Health Alliance, Nonin Medical is dedicated to developing low power, interoperable technology to reduce healthcare costs and improve quality of life. Since certifying the world's first Continua™-Certified product in 2009, the company continues to drive global connectivity standards and add interoperable solutions across its product line. For more information, visit www.nonin.com/ehealth.

American Telemedicine Association (ATA) 2011
Nonin Medical Booth 306


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning
2. Newtech, Inc., a Leading Chinese EMS Patient Monitoring Company, Partners With Masimo to Incorporate rainbow® SET Noninvasive Measurement Capabilities Into New Patient Monitors
3. New Studies Show Clinical Advantages of Masimo Noninvasive Hemoglobin, PVI, and Perfusion Index in Critically-ill Patients
4. Mater Childrens Hospital in Australia Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
5. Mafraq Hospital Becomes First in United Arab Emirates to Deploy Masimo rainbow SET Pulse CO-Oximetry for State-of-the-Art Noninvasive Patient Monitoring
6. Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors
7. New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
8. Nonin Medical, Inc. Launches New WristOx2™, Model 3150 in U.S. and Canada
9. Nonin Medical Announces Microsoft® HealthVault™ Certification of World’s First Continua™-Certified, Bluetooth® Wireless Fingertip Pulse Oximeter at CES 2011
10. BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States
11. Cheetah Medicals NICOM(R) System for Noninvasive Hemodynamic Monitoring Found to be an Effective Tool for Identification of Acute Heart Failure in the Emergency Department
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):